Increased polyol pathway due to aldose reductase activation and advanced glycation endproducts (AGEs) formation have been implicated as an important molecular mechanism of how hyperglycemia causes diabetic complications.
, 2, 3) which has been demonstrated to play important roles not only in the cataract formation in the lens 4) but also in the pathogenesis of diabetic complications such as neuropathy, 5) nephropathy 6) and retinopathy. 7) Prolonged hyperglycemia can also result in the formation of AGEs in body tissues. The complex, fluorescent AGE molecules formed during the Maillard reaction can lead to protein cross-linking and contribute to the development and progression of several diabetic complications such as cataract, atherosclerosis, nephropathy and neuropathy. 8) Since the discovery that ALR2 and AGEs may play an important role in pathogenesis of diabetic complications, several synthetic and naturally occurring compounds have been studied for their in vitro and in vivo activities. Several studies of naturally occurring flavonoids on the inhibition of ALR2 and AGEs, and their structure-activity relationship have been reported. [9] [10] [11] Increased oxidative stress is a widely accepted participant in the development and progression of diabetes and their complications. Diabetes is usually accompanied by an increased production of free radicals and/or impaired antioxidant defenses. 12, 13) It would therefore seem desirable that ALR2 inhibitors possess AGEs inhibitory and antioxidative potencies.
Rhus verniciflua grows particularly in South East Asia and the biological activities of this plant have been reported as anti-inflammatory, 14) anti-cancer, 15) and anti-rheumatoid arthritis, 16) etc.
In the present study, we investigated the inhibitory effect of the bark of R. verniciflua on ALR2 and AGEs to evaluate its potential use for the treatment of diabetic complications. This investigation led to the isolation and identification of the compounds that inhibit the activity of ALR2 and AGEs. Furthermore, we investigated whether the active compound for ALR2 and AGEs was able to scavenge free radical using luminometry (Photochem ® ).
MATERIALS AND METHODS
Chemicals First grade solvents were used for extraction, fractionation and column chromatography. Kiesel gel 60 (70-230 mesh, Art, 7734 Merck) was used as the column packing material. Kiesel 60 F 254 (precoated plate, Art. 5559, Merck) was used for thin layer chromatography (TLC). Iodine vapor and 10% H 2 SO 4 were used for TLC detection. DLGlyceraldehyde, D-glucose, bovine serum albumin (BSA), DTT and NADPH were purchased from Sigma Chemical (St. Louis, MO, U.S.A.). Ampicillin, IPTG and imidazole were purchased from USB Corporation (Cleveland, OH, U.S.A.). Human ALR2 cDNA clone was purchased from 21C Frontier Human Gene Bank (Daejeon, Korea).
Plant Materials The bark of R. verniciflua was purchased in the Kyungdong market, Korea and the voucher specimen (DGR-1001) was deposited at the Herbarium of KIST Gangneung Institute, Korea.
Isolation and Identification The dried bark of R. verniciflua (1.5 kg) was extracted four times with hot ethanol for 4 h. This residue was evaporated in vacuo to yield the total extract (130.0 g). This extract was then suspended in distilled water and partitioned sequentially with n-hexane, methylene chloride, ethyl acetate, and n-butanol. The ethyl acetate fraction (21.9 g) was subjected to silica gel chromatography eluted with methylene chloride and increasing proportion methanol from CH 2 Cl 2 -MeOH 10 : 0 (2 l) to 5 : 5 (2 l) to pro-vide 6 fractions (Fraction 1-6) .
From fraction 2, compounds 1-8 were isolated using preparative RP-HPLC (YMC J'sphere-H80, 4 mm, 250ϫ 20 mm), and recycling preparative RP-HPLC (LC-9104, Japan Analytical Industry). Compound 9 was purified from fraction 3 using a RP-HPLC (YMC J'sphere-H80, 4 mm, 250ϫ20 mm). All compounds identified by LC-MS and NMR spectra and direct comparison with authentic compounds. Their chemical structures are shown in Fig. 1 .
Preparation of Recombinant Human ALR2 (rhALR2) Open reading frame of human ALR2 was amplified by PCR and inserted into E. coli expression vector pET-23b (Merck, Darmstadt, Germany). Then the recombinant expression plasmid was transformed into E. coli BL21 (DE3) host strain. The transformant was grown in LB broth containing 50 mg/ml of ampicillin at 37°C, 200 rpm. When the absorbance at 600 nm reached 0.8, the expression of recombinant ALR2 was induced by IPTG and the culture continued at 30°C. After 4 h of additional culture, bacterial cells were harvested and stored at Ϫ20°C until further use. Further procedures were all performed at 4°C, except the lysis of bacterial cells, which was performed at room temperature. Harvested cells were lysed by adding 5 ml of BugBuster master mix lysis solution (Merck, Darmstadt, Germany) per 1 mg of wet cell. After adding about 3 volumes of binding buffer (20 mM Tris-Cl, pH 8.0, 0.5 M NaCl, 5 mM imidazole, and 1 mM DTT), cell lysates were centrifuged to remove cell debris. The supernatant was mixed with 1 ml of Ni-NTA resin (Merck, Darmstadt, Germany) on a twist shaker for 1 h.
Then, protein bound resin was collected by weak centrifugation and loaded onto a column. After washing with 10 column volumes of washing buffer (20 mM Tris-Cl, pH 8.0, 0.5 M NaCl, 20 mM imidazole, and 1 mM DTT), bound proteins were eluted with 4 ml of elution buffer (100 mM sodium phosphate, pH 6.2, 0.5 M NaCl, 250 mM imidazole, and 1 mM DTT). The concentration of the protein solution was determined by using Bradford dye (BioRad, CA, U.S.A.), and adjusted to a final concentration of 40 mM recombinant human ALR2. Small aliquots of enzyme solution were frozen with liquid nitrogen and stored at Ϫ80°C until further use.
Measurement of rhALR2 Activity rhALR2 activities were assayed spectrophotometrically by measuring the decrease in absorption of NADPH at 340 nm over a 5 min period with DL-glyceraldehyde as a substrate.
17) Each 1.0 ml cuvette contained equal units of enzyme, 0.10 M sodium phosphate buffer (pH 6.2), 0.3 mM NADPH with or without 10 mM substrate and inhibitor. The concentration of inhibitors giving 50% inhibition of enzyme activity (IC 50 ) was calculated from the least-squares regression line of the logarithmic concentrations plotted against the residual activity.
Determination of Inhibition-Type of rhALR2 by the Compound Reaction mixtures consisted of 0.1 M potassium phosphate (pH 7.0), 0.16 mM NADPH, 2 mM of rhALR2 with varied concentrations of substrate DL-glyceraldehyde and ALR2 inhibitors, epalrestat or butein in a total volume of 200 ml.
Concentrations were ranged from 0.02 to 0.2 mM for DLglyceraldehyde, from 0.5 to 1.5 mM for epalrestat, and from 1.0 to 2.0 mM for butein. rhALR2 activity was assayed spectrophotometrically by measuring the decrease in absorption of NADPH at 340 nm after substrate addition using BioTek Power Wave XS spectrophotometer (BioTek Instruments, VT, U.S.A.).
Effects on AGEs Formation The AGEs formation was assessed by characteristic fluorescence reported by Morimitsu et al. 18) with slight modifications. Briefly, the reaction mixture of 100 mg D-glucose, 10 mg BSA in 1 ml sodium phosphate buffer (67 mM, pH 7.2) was incubated at 60°C for 2 d with or without the test compound. The reaction solution (0.2 ml) was diluted with water (2 ml), and the intensity of fluorescence was measured using a fluorophotometer (Luminescence Spectrometer LS50B, Perkin-Elmer Ltd., England) at an excitation wavelength of 370 nm and an emission wavelength of 440 nm. The reaction mixture without D-glucose Antioxidative Capacity Determination For the determination of the integral antioxidative capacity of lipid soluble substances in R. verniciflua, the method of photochemiluminescence was used. ACL (Analitik Jena AG), where the luminol plays a double role as photosensitizer and also as oxygen radical detection reagent was used according to the manufacturer's instruction. 19) Results were calculated in Trolox equivalent.
RESULTS AND DISCUSSION
The present study was carried out in search of new potential ALR2 and AGEs inhibitors that would be useful for the treatment of diabetic complications from R. verniciflua.
In order to identify the active compounds from R. verniciflua, the extract divided into 5 systematic fractions, which were then tested for ALR2 inhibitory activity using DL-glyceraldehyde as a substrate and inhibitory effect on BSA glycation by a fluorescence method. Out of the fraction, ethyl acetate fraction showed a significantly higher inhibition which was concentration dependent (Tables 1, 2 ).
Ethyl acetate fraction was subjected to silica gel chromatographic separation to yield six subfractions and further purification of fraction 2 and 3 to yield nine phenolic compounds by preparative and recycling HPLC. The chemical structures of the isolated compounds, two simple phenolics, two flavanonols, one aurone, one chalcone and one tannin compounds were identified and their inhibitory effects on rhALR2 and AGEs are shown in Tables 3 and 4 .
Their chemical structures were elucidated by spectral analysis as; protocatechuic acid (1), ethyl gallate (2), fustin (3), morin hydrate (4), fisetin (5), sulfuretin (6), quercetin (7), butein (8) , and pentagalloyl glucose (9) . Their structures are shown in Fig. 1 . Inhibition rate was calculated as percentage with respect to the control value and expressed as meanϮstandard deviation of triplicate experiments. The concentration of each test sample giving rise to 50% inhibition of activity (IC 50 ) was estimated from the least-squares regression line of the logarithmic concentration plotted against inhibitory activity. a) Epalrestat was used as positive control. Inhibition rate was calculated as percentage with respect to the control value and expressed as meanϮstandard deviation of triplicate experiments. The concentration of each test sample giving rise to 50% inhibition of activity (IC 50 ) was estimated from the least-squares regression line of the logarithmic concentration plotted against inhibitory activity. a) Aminoguanidine was used as positive control. Inhibition rate was calculated as percentage with respect to the control value and expressed as meanϮstandard deviation of triplicate experiments. The concentration of each test sample giving rise to 50% inhibition of activity (IC 50 ) was estimated from the least-squares regression line of the logarithmic concentration plotted against inhibitory activity. a) Epalrestat was used as positive control. Inhibition rate was calculated as percentage with respect to the control value and expressed as meanϮstandard deviation of triplicate experiments. The concentration of each test sample giving rise to 50% inhibition of activity (IC 50 ) was estimated from the least-squares regression line of the logarithmic concentration plotted against inhibitory activity. a) Aminoguanidine was used as positive control.
Of these compounds, butein (8) exhibited the strongest inhibitory activity against rhALR2 with an IC 50 value of 0.7 mM, and sulfuretin (6) exhibited the strongest inhibitory activity against AGEs with an IC 50 value of 124.0 mM.
In our previous study, we hypothesized about the possible structure activity relationships to the inhibitory activities of chalcones, and concluded that butein was the most potent inhibitor for ALR2 as it possesses catechol moiety at the B ring and 4Ј-hydroxyl at the A ring. 20) From the result, the inhibitory effect of Rhus verniciflua on rhALR2, especially ethyl acetate fraction, is possibly due to butein acting as an active component.
Kinetic analysis of the inhibitory activity of butein against rhALR2 using Lineweaver-Burk plots of 1/velocity and 1/concentration of substrate was evaluated (data not shown). According to the result, inhibition of rhALR2 by epalrestat and butein was uncompetitive, meaning that both were unable to bind to neither the substrate binding region nor the NADPH binding region of rhALR2.
In this study, the phenomenon of protein glycation was demonstrated in the reaction mixture of BSA with glucose in vitro. Glucose is used as glycated agent, which is commonly adopted in Maillard reaction studies, and BSA could serve as targets for glycated agent.
11) As a similar result to ALR2 inhibitory activity, sulfuretin (6) and butein (8) showed the strongest AGEs inhibition, and the inhibitory potencies as expressed by IC 50 values, were 124.0 and 210.3 mM, respectively.
It has been reported that the hydroxyl groups of flavones at the 3Ј-, 4Ј-, 5-, and 7-positions increased the AGEs inhibitory activities and the methylation or glycosilation of the 3Ј-or 4Ј-hydroxyl group reduced the activity. 11, 21) In agreement with this report, the ring opening form of the 3-, 4-, 2Ј-, and 4Ј-tetrahydroxylated flavone, butein increased the activity.
It has been suggested that in diabetes oxidative stress plays a key role in the pathogenesis of vascular complications, both microvascular and macrovascular, and an early marker of such damage is the development of endothelial dysfunction. 22, 23) A large body of evidence suggests a possible role of oxidative stress in the pathogenesis of diabetic complications, and this raises the concept that antioxidant therapy may be of great interest to these patients. Recently, a hyperglycemia-induced process of overproduction of the superox- ide anion radical (O 2 Ϫ ) by the mitochondrial electron transport chain was reported to partially inhibit the glycolytic enzyme glyceraldehyde phosphatase dehydrogenase, thereby diverting upstream metabolites from glycolysis into the polyol pathway and AGEs formation, etc.
1)
For the quantitative measurement of antioxidative activity of ethyl acetate fraction, butein and sulfuretin, Photochem ® apparatus were used. Free radicals were generated by the instrument by means of a photosensitizer. The free radicals thus generated were detected by their reaction with a chemiluminogenic substance, luminol in this way can act both as photosensitizer as well as the detecting reagent. 24) If antioxidants are added to this measuring system, the intensity of the photochemiluminescence signal is attenuated dependent on concentration. In this way, the total antioxidative capacity of the samples under investigation can be quantified. The antioxidative capacity is given in equivalent concentration units of Trolox for lipid-soluble substances.
The antioxidative capacity of EtOAc fraction of this plant was measured as 7.23, 2.54 and 1.16 nmol equivalents of Trolox at 125.0, 12.5 and 1.25 ng/ml, respectively. Butein and sulfuretin, isolated from this plant have antioxidative capacity as 3.46 and 1.90 nmol equivalents of Trolox at 62.5 nM, respectively (Fig. 2) .
Overall findings suggest, therefore, the EtOAc fraction from R. verniciflua had antioxidative activity as well as ALR2 and AGEs inhibitory effects. Especially, butein and sulfuretin isolated from EtOAc fraction of this plant were possibly acting as active compounds. As a result, R. verniciflua could be offered as leading natural products for further study as a new natural products drug for diabetic complications, and butein and sulfuretin could be offered as active materials of standardization for developing as natural products functional food or medicines.
